Cargando…

Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment

PURPOSE: To investigate the effectiveness of mineralocorticoid receptor (MR) antagonist in patients with steroid-induced central serous chorioretinopathy (CSC). METHODS: A retrospective review was conducted of steroid-induced CSC patients who were treated with the MR antagonist spironolactone 50 mg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin Young, Chae, Ju Byung, Kim, Jisoo, Kim, Dong Yoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081588/ https://www.ncbi.nlm.nih.gov/pubmed/30140452 http://dx.doi.org/10.1155/2018/4258763

Ejemplares similares

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
por: Chin, Eric K, et al.
Publicado: (2015)

Predictive factors of selective mineralocorticoid receptor antagonist treatment in chronic central serous chorioretinopathy
por: Gergely, Róbert, et al.
Publicado: (2020)

Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses
por: Felipe, Camila Q., et al.
Publicado: (2022)

Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
por: Agarwal, Rajiv, et al.
Publicado: (2020)

Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy
por: Sawaguchi, Shota, et al.
Publicado: (2022)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis
por: Grixti, Andre, et al.
Publicado: (2013)

Retinal and choroidal changes in steroid-associated central serous chorioretinopathy
por: Ambiya, Vikas, et al.
Publicado: (2018)

Central serous chorioretinopathy with and without steroids: A multicenter survey
por: Araki, Takashi, et al.
Publicado: (2019)

Bilateral central serous chorioretinopathy with retinal pigment epithelium tears following epidural steroid injection
por: Lee, Sung-Bok, et al.
Publicado: (2013)

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy
por: Daruich, Alejandra, et al.
Publicado: (2016)

Assessment of metamorphopsia in patients with central serous chorioretinopathy
por: Bae, Sin Woo, et al.
Publicado: (2013)

Multifocal Central Serous Chorioretinopathy Associated with Steroids in a Patient with Myasthenia Gravis
por: Stefaniotou, Maria, et al.
Publicado: (2013)

Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use
por: Alsberge, Joseph B., et al.
Publicado: (2022)

Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease
por: Rahman, Asadur, et al.
Publicado: (2023)

Atypical Presentation of Choroidal Folds: Steroid-induced Central Serous Chorioretinopathy-like Maculopathy
por: Değirmenci, Cumali, et al.
Publicado: (2019)

Update on the pathophysiology and treatment of central serous chorioretinopathy
por: Yu, Seung-Young
Publicado: (2022)

Advances in the treatment of central serous chorioretinopathy
por: Abouammoh, Marwan A.
Publicado: (2015)

Central Serous Chorioretinopathy: Treatment with Laser
por: Battaglia Parodi, Maurizio, et al.
Publicado: (2020)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2021)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2022)

Class-specific responses of brown adipose tissue to steroidal and nonsteroidal mineralocorticoid receptor antagonists
por: Marzolla, V., et al.
Publicado: (2021)

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
por: Folkerts, Kerstin, et al.
Publicado: (2022)

The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
por: Kintscher, Ulrich, et al.
Publicado: (2023)

Steroid-induced central serous chorioretinopathy in a patient with non-arteritic anterior ischemic optic neuropathy
por: Alkin, Zeynep, et al.
Publicado: (2015)

“Old wine in a new bottle” - post COVID-19 infection, central serous chorioretinopathy and the steroids
por: Sanjay, Srinivasan, et al.
Publicado: (2021)

Traumatic central serous chorioretinopathy in the fellow eye
por: Yu, Seung-Young, et al.
Publicado: (2016)

FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY
por: Han, Jisang, et al.
Publicado: (2020)

Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016)

Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani, Sepehr, et al.
Publicado: (2019)

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628
por: Ma, Frank Y., et al.
Publicado: (2015)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Steroid-induced central serous retinopathy
por: Shah, Samidh P., et al.
Publicado: (2011)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Subthreshold Continuous Wave Autofluorescence-controlled Laser Treatment of Chronic Central Serous Chorioretinopathy
por: Ashraf, Hossein, et al.
Publicado: (2018)

Low-dose aspirin as treatment for central serous chorioretinopathy
por: Caccavale, Antonio, et al.
Publicado: (2010)

Topical Nepafenac in Treatment of Acute Central Serous Chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2013)

The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy
por: Da Pozzo, Stefano, et al.
Publicado: (2021)

Diagnosis and Treatment of Central Serous Chorioretinopathy in Patients with Scleritis
por: Tsai, Yu-Chien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_60gv4qd0sju2ue682gbu0g41bc